N/A N=22 Cryolipolysis and Subcision for Treatment of Cellulite
Cellulite
Primary: Blinded Rating of the Treatment Area (Cryolipolysis vs. Subcision) With the Best Cosmetic Appearance. — 22.22; 33.33; 44.44 Percentage of participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=97 Effects on Cellulite Appearance
Body Fat Disorder
Primary: Percentage of Photographs Correctly Identified by Blinded Reviewers From the Independent Physician Reviewer Panel — 55.7 % of images identified correctly
N/A N=45 CoolSculpting of the Flank With Alternate Treatment Parameters
Body Fat Disorder
Primary: The Number of Device and/or Procedure-Related Adverse Events — 12 device or procedure-related AEs
N/A N=31 Profound Dermal and SubQ Cartridges for the Treatment of Cellulite
Cellulite
Primary: Improvement in Global Aesthetic Appearance of Cellulite in Treated Areas, as Assessed by Study Investigator Evaluations — 11; 7; 4; 16 Investigator Assessments
Phase 2 N=64 Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite)
Edematous Skin
Primary: Aesthetic Appearance Improvement Likert Scores by Treatment Region at Day 22 — 1.08; 1.10; 0.75; 0.50 score on a scale
N/A N=20 Evaluation of CoolSculpt Combining Venus Legacy Technology for Enhanced Results in Fat Reduction & Laxity of the Flanks
Adipose Tissue
Primary: General Improvement in Skin Laxity of the Flank Area — 1.1; 2.1 units on a scale — p=<0.01
N/A N=15 Clinical Evaluation of CelluTite Treatment
Cellulite of Thighs
Primary: Change in Cellulite Score Rated According to Cellulite Severity Scale (Dimples) — 2.45 score on a scale
Phase 3 N=422 Effectiveness and Safety of EN3835 in the Treatment of Cellulite in Women
Edematous Fibrosclerotic Panniculopathy (Cellulite)
Primary: 2-level Composite Responders for the Target Buttock — 12; 1; 202; 205 Participants — p=0.002
Phase 2 N=35 CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques
Edematous Fibrosclerotic Panniculopathy · Cellulite · Laxity; Skin
Primary: Percentage of 1-Level Responders (+1 or Better Score) on the Investigator-Global Aesthetic Improvement Scale (I-GAIS) for Either Buttock or Either Thigh — 85.7; 87.5…
N/A N=45 Non-Invasive Reduction of Fat in the Inner Thighs
Body Fat Disorder
Primary: Percentage of Pre-Treatment Images Correctly Identified by Reviewers — 90.5 percentage of correct identifications
Phase 3 N=423 Effectiveness and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women
Edematous Fibrosclerotic Panniculopathy (Cellulite)
Primary: 2-level Composite Responders for the Target Buttock — 16; 4; 194; 209 Participants — p=0.006
N/A N=25 Non-Invasive Reduction of Fat in the Flanks of Patients With Sharp Body Curvature
Body Fat Disorder
Primary: Safety of the Zeltiq System for Non-invasive Fat Reduction in Subjects With Greater Flank Curvature. — 0; 0 UADEs
N/A N=50 CoolSculpting and EMS for the Abdomen
Body Fat Disorder
Primary: Number of Unanticipated Adverse Device Effects (UADE) — 0; 0; 0; 0 events
Phase 4 N=48 Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite
Edematous Fibrosclerotic Panniculopathy (EFP) · Cellulite
Primary: Number of Participants by Buttock at Each Level of Bruising on the Investigator Assessment of Bruising Severity Scale at Day 4 — 0; 0; 0; 0 Participants
N/A N=70 SlimShape Device for Abdominal Fat and Circumference Reduction
Fat Disorder
Primary: Change in Fat Thickness at Final Follow-up Compared to Baseline — -1.76 millimeters
Phase 2 N=12 Evaluation of Safety and Efficacy of RZL-012 in Subjects Seeking Fat Reduction in the Flanks
Flank Mass
Primary: Number of Participants With Treatment-related Adverse Events [AEs] — 12; 12; 9; 12 participants
Phase 4 N=59 A Study to Assess the Adverse Events and Effectiveness of Rapid Acoustic Pulse (RAP) Device in Adult Participants for the Appearance of Cellulite
Cellulite
Primary: Percentage of Before and After Side-by-side Photographs Correctly Identified by At Least 2 of 3 Blinded Reviewers From the Independent Physician Reviewer (IPR) Panel…
N/A N=68 Study of the Effect of Low Level Laser Light Therapy on Reducing the Appearance of Cellulite in the Thighs and Buttocks.
Cellulite
Primary: Number of Subjects That Met the Individual Success Criteria — 19; 3 participants — p=<0.0001
Phase 4 N=14 A Study to Assess the Adverse Events and Effectiveness of Rapid Acoustic Pulse (RAP) Device for the Appearance of Cellulite in Adult Participants
Cellulite
Primary: Percentage of Before and After Side-by-side Photographs Correctly Identified by At Least 2 of 3 Blinded Reviewers From the Independent Physician Reviewer (IPR) Panel…
Phase 2 N=259 EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Edematous Fibrosclerotic Panniculopathy · Cellulite
Primary: Number of Participants That Were 2-level Composite (CR-PCSS and PR-PCSS) Responders During the Observation Phase — 19; 0; 16; 0 Participants
N/A N=19 Fat Layer Reduction in the Lateral Thighs Using CoolSculpting
Body Fat Disorder
Primary: Safety of the Zeltiq CoolSculpting System in the Outer Thighs — 8; 0 events
N/A N=16 VelaShape III & UltraShape Power for Thigh Circumference Reduction
Circumference Reduction
Primary: Circumference Change in the Thighs at the 12-week Follow-up Compared to Baseline Measurements — -2.8 centimeter
Phase 2 N=150 A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Edematous Fibrosclerotic Panniculopathy (EFP)
Primary: Investigator Global Assessment of Aesthetic Improvement — 0.7; 0.9; 1.1; 0.5 units on a scale
Phase 3 N=153 Real World CCH Study in Adult Females With Cellulite
Edematous Fibrosclerotic Panniculopathy (EFP) · Cellulite
Primary: The Proportion of Participants With Improved (+1 or Better) Score on I-GAIS for Either Posterolateral Thigh — 58 Participants
N/A N=60 Non-Invasive Reduction of Abdominal Fat
Fat Reduction
Primary: Proportion of Pre-treatment Images Correctly Identified — 128 photos — p=<0.001
Phase 4 N=5 To Assess the Effectiveness of Multiple Dose, Multiple Concentrations of Qwo, for the Treatment of Mild to Moderate Cellulite.
Cellulite
Primary: Proportion of Subjects With ≥1-point Improvement on Investigator Global Aesthetic Improvement Scale (I-GAIS) at Day 90 (Buttocks) — 3; 2 Participants
Phase 4 N=110 CoolSculpting® Elite for Non-Invasive Fat Reduction
Non-invasive Fat Reduction
Primary: Percentage of Participants With "Satisfied" or "Very Satisfied" on Item #1 for the CSQ (Cryolipolysis Satisfaction Questionnaire) - Midsection — 83.3 percentage of…
N/A N=75 Trim II for Noninvasive Lipolysis and Circumference Reduction of Abdomen.
Circumference Reduction of Abdomen
Primary: Evaluation of Change in Abdomen Circumference Using Tape Measurements in cm at the 3 Months Follow-up Visit Comparing to Baseline. — 89.5 CM
N/A N=15 CoolSculpting Treatment in the Upper Arms
Body Fat Disorder
Primary: Proportion of Correctly Identified Pre-treatment Photos — 26 photos
N/A N=12 Performance Evaluation of the truSculpt Radiofrequency Device for Lipolysis of Abdominal Fat
Body Fat
Primary: Number of Participants Who's Abdominal Tissue Showed Necrosis or Inflammatory Immune Cell Response — 10; 0 Participants